Solesence, Inc. Common Stock(SLSN)Earnings, Financials & Key RatiosSolesence, Inc. Common Stock (SLSN) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
the company's precarious liquidity position, highlighted by a cash balance of only $573,000 against $22.3 million in total debt, suggests significant financial risk for prospective investors.
Solesence, Inc. Common Stock (SLSN) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Solesence, Inc. Common Stock (SLSN) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 12, 2026 | $0.01 | $13M |
| Q2 2026 | Mar 31, 2026 | $0.00 | $12M |
| Q4 2025 | Nov 11, 2025 | $0.02 | $15M |
| Q3 2025 | Jul 31, 2025 | $0.04 | $20M |
Recent stock market news and headlines for Solesence, Inc. Common Stock (SLSN)
Global Award Recognizes Excellence in Service, Reliability, and Innovation ROMEOVILLE, Ill., June 18, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc.
Key metrics vs top competitors for Solesence, Inc. Common Stock (SLSN)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $0.72 | $50.71M | 35.90 | 18.56% | 2.88% | 10.99% | — | |
| $1.11 | $143.86M | -6.94 | -10.02% | -2.03% | -9.41% | — | |
| $22.54 | $1.61B | 26.21 | 8.48% | 5.05% | 12.84% | — | |
| $75.34 | $4.48B | 171.23 | 24.59% | 3.34% | 5.16% | — | |
| $2.23 | $1.96B | -5.07 | -3.68% | -9.26% | -14.13% | — | |
| $122.25 | $3.92B | 23.33 | 2.49% | 13.46% | 18.37% | — |
Solesence, Inc. Common Stock (SLSN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Solesence, Inc. Common Stock (SLSN) SEC filings — annual & quarterly reports (10-K, 10-Q)
May 12, 2026·SEC
Apr 29, 2026·SEC
Mar 31, 2026·SEC
Get notified when SLSN posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Solesence, Inc. Common Stock (SLSN) stock FAQ — growth, dividends, profitability & financials explained
Solesence, Inc. Common Stock (SLSN) reported $60.4M in revenue for fiscal year 2025. This represents a 105% increase from $29.5M in 2021.
Solesence, Inc. Common Stock (SLSN) grew revenue by 18.6% over the past year. This is strong growth.
Yes, Solesence, Inc. Common Stock (SLSN) is profitable, generating $0.9M in net income for fiscal year 2025 (2.9% net margin).
Solesence, Inc. Common Stock (SLSN) has a return on equity (ROE) of 11.0%. This is reasonable for most industries.
Solesence, Inc. Common Stock (SLSN) had negative free cash flow of $2.2M in fiscal year 2025, likely due to heavy capital investments.
